Description

Homoserine, n-(6,9-Dihydro-6-Oxo-9--Bta--D-Ribofuranosyl-1H-Purin-2-Yl)- (9Ci) is a specialized nucleoside derivative of significant interest in advanced biochemical research and pharmaceutical development. This compound matters for its role as a key intermediate or reference standard in the synthesis and study of modified nucleosides, which are crucial for exploring novel therapeutic agents and understanding cellular processes. It is primarily needed by research institutions, pharmaceutical R&D departments, and fine chemical manufacturers focused on antiviral, anticancer, or nucleotide-based drug discovery.

Application

• Pharmaceutical Research & Development: Serves as a critical building block or reference standard in the synthesis of novel nucleoside analogs for potential therapeutic applications.
• Antiviral/Anticancer Agent Discovery: Used as a key intermediate in the research and development of new nucleotide-based drugs targeting viral replication or cancer cell proliferation.
• Biochemical Research: Employed in enzymatic studies, metabolic pathway analysis, and as a substrate or inhibitor in studies of purine and nucleoside metabolism.
• Fine Chemical Synthesis: Acts as a specialized starting material or intermediate for the custom synthesis of complex, high-value molecules for research purposes.
• Academic Research: Utilized in university and institutional labs for fundamental studies in organic chemistry, medicinal chemistry, and molecular biology.
• Process Development & Scale-up: Supports process chemistry teams in developing and optimizing synthetic routes for nucleoside-based active pharmaceutical ingredients (APIs).

Basic Information

Product Name	Homoserine, n-(6,9-Dihydro-6-Oxo-9--Bta--D-Ribofuranosyl-1H-Purin-2-Yl)- (9Ci)
CAS No.	220789-22-0
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	9-β-D-Ribofuranosyl-6-oxo-6,9-dihydro-1H-purin-2-yl-homoserine; 2-(Homoserinyl)-6-oxopurine riboside; N-(6,9-Dihydro-6-oxo-9-β-D-ribofuranosyl-1H-purin-2-yl)homoserine; 2-Homoserinyl-6-oxopurine nucleoside; Homoserine-purine riboside derivative; 220789-22-0; (9Ci) Homoserine derivative
EINECS	Contact for details

Quality Control

Our Homoserine, n-(6,9-Dihydro-6-Oxo-9--Bta--D-Ribofuranosyl-1H-Purin-2-Yl)- (9Ci) is produced and handled under strict quality management protocols to ensure batch-to-batch consistency and reliability for research applications. All products undergo rigorous analytical testing, including HPLC for purity assessment and spectroscopic methods for structural confirmation. Certificates of Analysis (COA) detailing identity, purity, and related substances are available upon request to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area. Due to its hygroscopic (moisture-sensitive) nature, it is recommended to store the product under an inert atmosphere or with appropriate desiccants to maintain stability. For long-term storage, conditions of 2-8°C are advised.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Residual Solvents (GC)	Complies with ICH limits

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.